化學材料

Polatuzumab vedotin-piiq (anti-CD79b)

Polatuzumab vedotin-piiq (anti-CD79b)

AL-AB175635 / 10MG
CAS:1313206-42-6
加入洽詢
Quilizumab (anti-IgE)

Quilizumab (anti-IgE)

AL-AB175636 / 100ΜG
CAS:1228538-47-3
加入洽詢
Quilizumab (anti-IgE)

Quilizumab (anti-IgE)

AL-AB175636 / 5MG
CAS:1228538-47-3
加入洽詢
Quilizumab (anti-IgE)

Quilizumab (anti-IgE)

AL-AB175636 / 1MG
CAS:1228538-47-3
加入洽詢
Quilizumab (anti-IgE)

Quilizumab (anti-IgE)

AL-AB175636 / 10MG
CAS:1228538-47-3
加入洽詢
Racotumomab (anti-GM3)

Racotumomab (anti-GM3)

AL-AB175638 / 10MG
CAS:946832-34-4
加入洽詢
Racotumomab (anti-GM3)

Racotumomab (anti-GM3)

AL-AB175638 / 5MG
CAS:946832-34-4
加入洽詢
Racotumomab (anti-GM3)

Racotumomab (anti-GM3)

AL-AB175638 / 1MG
CAS:946832-34-4
加入洽詢
Racotumomab (anti-GM3)

Racotumomab (anti-GM3)

AL-AB175638 / 100ΜG
CAS:946832-34-4
加入洽詢
Retifanlimab (anti-PD-1)

Retifanlimab (anti-PD-1)

AL-AB175644 / 1MG
CAS:2079108-44-2
加入洽詢
Retifanlimab (anti-PD-1)

Retifanlimab (anti-PD-1)

AL-AB175644 / 5MG
CAS:2079108-44-2
加入洽詢
Retifanlimab (anti-PD-1)

Retifanlimab (anti-PD-1)

AL-AB175644 / 10MG
CAS:2079108-44-2
加入洽詢
Retifanlimab (anti-PD-1)

Retifanlimab (anti-PD-1)

AL-AB175644 / 100ΜG
CAS:2079108-44-2
加入洽詢
Rontalizumab (anti-IFNA1)

Rontalizumab (anti-IFNA1)

AL-AB175647 / 1MG
CAS:948570-30-7
加入洽詢
Rontalizumab (anti-IFNA1)

Rontalizumab (anti-IFNA1)

AL-AB175647 / 5MG
CAS:948570-30-7
加入洽詢
Rontalizumab (anti-IFNA1)

Rontalizumab (anti-IFNA1)

AL-AB175647 / 100ΜG
CAS:948570-30-7
加入洽詢
Rontalizumab (anti-IFNA1)

Rontalizumab (anti-IFNA1)

AL-AB175647 / 10MG
CAS:948570-30-7
加入洽詢
Rovelizumab (anti-CD11a&CD18)

Rovelizumab (anti-CD11a&CD18)

AL-AB175649 / 1MG
CAS:339086-79-2
加入洽詢
Rovelizumab (anti-CD11a&CD18)

Rovelizumab (anti-CD11a&CD18)

AL-AB175649 / 10MG
CAS:339086-79-2
加入洽詢
Rovelizumab (anti-CD11a&CD18)

Rovelizumab (anti-CD11a&CD18)

AL-AB175649 / 5MG
CAS:339086-79-2
加入洽詢
Rovelizumab (anti-CD11a&CD18)

Rovelizumab (anti-CD11a&CD18)

AL-AB175649 / 100ΜG
CAS:339086-79-2
加入洽詢
Sacituzumab govitecan (anti-TROP2)

Sacituzumab govitecan (anti-TROP2)

AL-AB175650 / 1MG
CAS:1491917-83-9
加入洽詢
Sacituzumab govitecan (anti-TROP2)

Sacituzumab govitecan (anti-TROP2)

AL-AB175650 / 5MG
CAS:1491917-83-9
加入洽詢
Sacituzumab govitecan (anti-TROP2)

Sacituzumab govitecan (anti-TROP2)

AL-AB175650 / 10MG
CAS:1491917-83-9
加入洽詢
Sacituzumab govitecan (anti-TROP2)

Sacituzumab govitecan (anti-TROP2)

AL-AB175650 / 100ΜG
CAS:1491917-83-9
加入洽詢
Satralizumab (anti-IL-6Ra)

Satralizumab (anti-IL-6Ra)

AL-AB175651 / 10MG
CAS:1535963-91-7
加入洽詢
Satralizumab (anti-IL-6Ra)

Satralizumab (anti-IL-6Ra)

AL-AB175651 / 100ΜG
CAS:1535963-91-7
加入洽詢
Satralizumab (anti-IL-6Ra)

Satralizumab (anti-IL-6Ra)

AL-AB175651 / 5MG
CAS:1535963-91-7
加入洽詢
Satralizumab (anti-IL-6Ra)

Satralizumab (anti-IL-6Ra)

AL-AB175651 / 1MG
CAS:1535963-91-7
加入洽詢
ZWB67

ZWB67

AL-AB175652 / 5MG
CAS:1933514-13-6
加入洽詢
ZWB67

ZWB67

AL-AB175652 / 1MG
CAS:1933514-13-6
加入洽詢
Seribantumab (anti-ERBB3)

Seribantumab (anti-ERBB3)

AL-AB175653 / 10MG
CAS:1334296-12-6
加入洽詢
Seribantumab (anti-ERBB3)

Seribantumab (anti-ERBB3)

AL-AB175653 / 100ΜG
CAS:1334296-12-6
加入洽詢
Seribantumab (anti-ERBB3)

Seribantumab (anti-ERBB3)

AL-AB175653 / 5MG
CAS:1334296-12-6
加入洽詢
Seribantumab (anti-ERBB3)

Seribantumab (anti-ERBB3)

AL-AB175653 / 1MG
CAS:1334296-12-6
加入洽詢
Sirukumab (anti-IL-6)

Sirukumab (anti-IL-6)

AL-AB175656 / 5MG
CAS:1194585-53-9
加入洽詢
Sirukumab (anti-IL-6)

Sirukumab (anti-IL-6)

AL-AB175656 / 1MG
CAS:1194585-53-9
加入洽詢
Sirukumab (anti-IL-6)

Sirukumab (anti-IL-6)

AL-AB175656 / 10MG
CAS:1194585-53-9
加入洽詢
Sirukumab (anti-IL-6)

Sirukumab (anti-IL-6)

AL-AB175656 / 100ΜG
CAS:1194585-53-9
加入洽詢
Solanezumab (anti-Amyloid Beta)

Solanezumab (anti-Amyloid Beta)

AL-AB175657 / 1MG
CAS:955085-14-0
加入洽詢
Solanezumab (anti-Amyloid Beta)

Solanezumab (anti-Amyloid Beta)

AL-AB175657 / 5MG
CAS:955085-14-0
加入洽詢
Solanezumab (anti-Amyloid Beta)

Solanezumab (anti-Amyloid Beta)

AL-AB175657 / 10MG
CAS:955085-14-0
加入洽詢
Solanezumab (anti-Amyloid Beta)

Solanezumab (anti-Amyloid Beta)

AL-AB175657 / 100ΜG
CAS:955085-14-0
加入洽詢
Spesolimab (anti-IL-1RL2)

Spesolimab (anti-IL-1RL2)

AL-AB175661 / 1MG
CAS:2097104-58-8
加入洽詢
Spesolimab (anti-IL-1RL2)

Spesolimab (anti-IL-1RL2)

AL-AB175661 / 100ΜG
CAS:2097104-58-8
加入洽詢
Spesolimab (anti-IL-1RL2)

Spesolimab (anti-IL-1RL2)

AL-AB175661 / 10MG
CAS:2097104-58-8
加入洽詢
Spesolimab (anti-IL-1RL2)

Spesolimab (anti-IL-1RL2)

AL-AB175661 / 5MG
CAS:2097104-58-8
加入洽詢
Sugemalimab (anti-PD-L1)

Sugemalimab (anti-PD-L1)

AL-AB175662 / 1MG
CAS:2256084-03-2
加入洽詢
Sugemalimab (anti-PD-L1)

Sugemalimab (anti-PD-L1)

AL-AB175662 / 5MG
CAS:2256084-03-2
加入洽詢
Sugemalimab (anti-PD-L1)

Sugemalimab (anti-PD-L1)

AL-AB175662 / 100ΜG
CAS:2256084-03-2
加入洽詢
LOCATIONS

服務據點

北北基/宜蘭/花蓮
洽詢車

你的洽詢車總計 0 件產品

依據歐盟施行的個人資料保護法,我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」,代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況,以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
管理Cookies

隱私權偏好設定中心

依據歐盟施行的個人資料保護法,我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」,代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況,以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
查看隱私權政策

管理同意設定

必要的Cookie

一律啟用
網站運行離不開這些 Cookie 且您不能在系統中將其關閉。通常僅根據您所做出的操作(即服務請求)來設置這些 Cookie,如設置隱私偏好、登錄或填充表格。您可以將您的瀏覽器設置為阻止或向您提示這些 Cookie,但可能會導致某些網站功能無法工作。